FOLFIRINOX for advanced pancreatic adenocarcinoma in Brazil: a single-institution experience

Objective: Data is lacking about FOLFIRINOX use for advanced pancreatic ductal adenocarcinoma in emerging countries. The objective of this study was to report outcomes of efficacy and safety in the setting of a South American institution.

Bibliographic Details
Published in:Brazilian Journal of Oncology
Main Authors: José Mauricio Mota, Andre Henares Campos Silva, Andre Silva Franco, Aley Talans, Felipe Ribeiro-Ferreira, Tiago Biachi de Castria, Jorge Sabbaga, Paulo M. Hoff
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2018-01-01
Subjects:
Pancreatic neoplasms/drug therapy
FOLFIRINOX
Cohort studies
Brazil
Neoplasias pancreáticas/tratamento farmacológico
Estudos de coortes
Brasil
Online Access:http://www.thieme-connect.de/DOI/DOI?10.26790/BJO20181447A197

Internet

http://www.thieme-connect.de/DOI/DOI?10.26790/BJO20181447A197

Similar Items